Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BAR NYSE:CRL NASDAQ:REVB NASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBARGraniteShares Gold Trust$33.01+0.2%$32.80$23.24▼$34.04$1.13B0.15839,151 shs329,461 shsCRLCharles River Laboratories International$154.55-1.4%$147.42$91.86▼$254.15$7.70B1.491.04 million shs493,642 shsREVBRevelation Biosciences$2.95+3.9%$4.01$2.11▼$168.00$4.36M-0.08139,695 shs373,814 shsSKINBeauty Health$1.59-4.2%$1.75$0.78▼$2.38$209.15M1.22943,204 shs466,393 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBARGraniteShares Gold Trust-0.24%+0.43%-1.35%+0.55%+35.68%CRLCharles River Laboratories International+1.22%-4.14%+8.10%+48.14%-29.67%REVBRevelation Biosciences-4.38%+0.35%+19.83%-69.26%-96.77%SKINBeauty Health-3.49%-18.63%+8.50%+96.26%-20.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBARGraniteShares Gold TrustN/AN/AN/AN/AN/AN/AN/AN/ACRLCharles River Laboratories International4.7619 of 5 stars3.15.00.04.72.22.51.9REVBRevelation Biosciences0.9566 of 5 stars0.05.00.00.01.00.01.3SKINBeauty Health0.2897 of 5 stars0.80.00.00.02.13.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBARGraniteShares Gold Trust 0.00N/AN/AN/ACRLCharles River Laboratories International 2.25Hold$174.5412.93% UpsideREVBRevelation Biosciences 0.00N/AN/AN/ASKINBeauty Health 1.67Reduce$1.42-10.90% DownsideCurrent Analyst Ratings BreakdownLatest BAR, SKIN, REVB, and CRL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$170.00 ➝ $180.007/9/2025CRLCharles River Laboratories InternationalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$150.00 ➝ $200.005/23/2025CRLCharles River Laboratories InternationalRedburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$188.00 ➝ $182.005/14/2025CRLCharles River Laboratories InternationalCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy5/14/2025CRLCharles River Laboratories InternationalTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$179.005/8/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$145.00 ➝ $155.005/8/2025CRLCharles River Laboratories InternationalRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$118.00 ➝ $140.005/8/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$170.005/5/2025SKINBeauty HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.50 ➝ $1.25(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBARGraniteShares Gold TrustN/AN/AN/AN/AN/AN/ACRLCharles River Laboratories International$4.05B1.87$21.41 per share7.22$67.80 per share2.28REVBRevelation BiosciencesN/AN/AN/AN/A$27.05 per shareN/ASKINBeauty Health$334.30M0.60$0.06 per share26.25$0.41 per share3.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBARGraniteShares Gold TrustN/AN/A0.00∞N/AN/AN/AN/AN/ACRLCharles River Laboratories International$22.20M-$0.65N/A14.055.31-0.66%15.19%6.93%8/6/2025 (Estimated)REVBRevelation Biosciences-$15.04M-$307.86N/AN/AN/AN/A-299.46%-115.36%8/8/2025 (Estimated)SKINBeauty Health-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)Latest BAR, SKIN, REVB, and CRL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025SKINBeauty Health-$0.06N/AN/AN/AN/AN/A8/8/2025N/AREVBRevelation Biosciences-$4.46N/AN/AN/AN/AN/A8/6/2025Q2 2025CRLCharles River Laboratories International$2.50N/AN/AN/A$983.76 millionN/A5/8/2025Q1 2025REVBRevelation Biosciences-$20.64-$6.33+$14.31-$2.11N/AN/A5/8/2025Q1 2025SKINBeauty Health-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million5/7/2025Q1 2025CRLCharles River Laboratories International$2.06$2.34+$0.28$0.50$942.34 million$984.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBARGraniteShares Gold TrustN/A0.00%N/AN/AN/ACRLCharles River Laboratories InternationalN/AN/AN/AN/AN/AREVBRevelation BiosciencesN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBARGraniteShares Gold TrustN/AN/AN/ACRLCharles River Laboratories International0.781.431.16REVBRevelation BiosciencesN/A3.603.60SKINBeauty Health12.017.476.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBARGraniteShares Gold TrustN/ACRLCharles River Laboratories International98.91%REVBRevelation Biosciences12.80%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipBARGraniteShares Gold TrustN/ACRLCharles River Laboratories International1.30%REVBRevelation Biosciences2.30%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBARGraniteShares Gold Trust2,02134.10 millionN/ANot OptionableCRLCharles River Laboratories International20,10049.12 million48.48 millionOptionableREVBRevelation Biosciences101.53 million1.50 millionNot OptionableSKINBeauty Health1,030125.99 million74.34 millionOptionableBAR, SKIN, REVB, and CRL HeadlinesRecent News About These CompaniesClear Skin Through Ayurveda: Acne To Pigmentation Solved Naturally4 hours ago | msn.comNew Legislation Aims To Get Potentially Toxic Chemicals Out Of Your Beauty ProductsJuly 18 at 1:46 PM | msn.com7 summer skin care tips you should never skipJuly 18 at 1:46 PM | msn.comVitamin C benefits for your skin: Brightens, hydrates and fights aging naturallyJuly 18 at 1:46 PM | msn.comThe 12 Essential K-Beauty Face Serums for Glowing Skin, According to a Korean Beauty ExpertJuly 18 at 1:46 PM | msn.comWhat beauty companies are selling to kidsJuly 17 at 12:48 PM | vox.comVMolly-Mae Hague reveals secret for glowing and blemish-free skin is ZO Skin’s Complexion PadsJuly 17 at 12:48 PM | msn.com‘Skin Longevity’: Why You’re Seeing This Beauty Buzzword EverywhereJuly 17 at 12:48 PM | msn.comUsing marigold extract for skin, wound healing, and moreJuly 17 at 7:47 AM | msn.comMeet The Korean Skin Care Ingredient That Fills Wrinkles Like MagicJuly 17 at 7:47 AM | msn.comAstaberry's 'Get the Rich Look': A New Era of Natural BeautyJuly 17 at 2:47 AM | devdiscourse.comDWill Trump’s tariffs make Korean beauty products unaffordable?July 17 at 2:47 AM | msn.comBeauty starts with nutrition: how what you eat affects your skinJuly 17 at 2:47 AM | wfla.comWThe 1 Overlooked Makeup Habit Dermatologists Warn Could Age Your Skin FasterJuly 17 at 2:47 AM | msn.comEXCLUSIVE: Menopause Solutions Company Alloy Is Doubling Down on Skin Care With Estrogen-based ProductsJuly 17 at 2:47 AM | msn.com6 Morning Drinks To Add To Your Everyday Beauty RoutineJuly 16 at 3:06 AM | idiva.comI12 Best New Drugstore Makeup Finds for Mature Skin, According to Celebrity Makeup ArtistsJuly 15 at 10:05 PM | aol.comAThis natural ingredient is ‘lowkey magic’ for your face — it fights acne, moisturizes and helps your skin barrierJuly 15 at 10:05 PM | msn.com15 Australian Beauty Brands to KnowJuly 15 at 10:55 AM | msn.comI’m a skin expert. This is why you should avoid ‘natural’ skincare hacks at all costsJuly 15 at 10:55 AM | msn.comBeauty Health (NASDAQ:SKIN) Stock Price Down 3.5% - Here's WhyJuly 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhat to Expect From the Q2 Earnings Reporting CycleBy Thomas Hughes | June 23, 2025View What to Expect From the Q2 Earnings Reporting Cycle3 Hot Tech Stocks Showing Bullish Price Action Right NowBy Thomas Hughes | July 11, 2025View 3 Hot Tech Stocks Showing Bullish Price Action Right NowSnag These 3 Bargain Tech Stocks Before They PopBy Gabriel Osorio-Mazilli | June 27, 2025View Snag These 3 Bargain Tech Stocks Before They PopNebius Group: Up 385%, Analysts Say It’s Still a BargainBy Jeffrey Neal Johnson | July 10, 2025View Nebius Group: Up 385%, Analysts Say It’s Still a Bargain3 High-Yield Bargains to Watch in 2025’s Second HalfBy Thomas Hughes | July 17, 2025View 3 High-Yield Bargains to Watch in 2025’s Second HalfBAR, SKIN, REVB, and CRL Company DescriptionsGraniteShares Gold Trust NYSEARCA:BAR$33.01 +0.08 (+0.24%) Closing price 04:10 PM EasternExtended Trading$33.08 +0.07 (+0.20%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The GraniteShares Gold Trust (BAR) is an exchange-traded fund that is based on the LBMA Gold Price index. The fund tracks the gold spot price, less trust expenses and liabilities, using physically held gold stored and secured in vaults in London. BAR was launched on Aug 31, 2017 and is managed by GraniteShares.Charles River Laboratories International NYSE:CRL$154.55 -2.15 (-1.37%) Closing price 03:59 PM EasternExtended Trading$154.07 -0.48 (-0.31%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.Revelation Biosciences NASDAQ:REVB$2.95 +0.11 (+3.87%) Closing price 04:00 PM EasternExtended Trading$2.95 0.00 (0.00%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.Beauty Health NASDAQ:SKIN$1.59 -0.07 (-4.22%) Closing price 04:00 PM EasternExtended Trading$1.61 +0.02 (+1.26%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
